EJP-CONCERT. D3.7 Second joint roadmap for radiation protection research

EJP-CONCERT Work Package 3, Deliverable 3.7

Future Supply of Medical Radioisotopes for the UK Report 2014

The UK has no research nuclear reactors and relies on the importation of 99Mo and other medical radioisotopes (e.g. Iodine-131) from overseas (excluding PET radioisotopes). The UK is therefore vulnerable not only to global shortages, but to problems with shipping and importation of the products. In this context Professor Erika Denton UK national Clinical Director for Diagnostics requested that the British Nuclear Medicine Society lead a working group with stakeholders including representatives from the Science & Technology Facilities Council (STFC) to prepare a report. The group had a first meeting on 10 April 2013 followed by a working group meeting with presentations on 9th September 2013 where the scope of the work required to produce a report was agreed. The objectives of the report are: to describe the status of the use of medical radioisotopes in the UK; to anticipate the potential impact of shortages for the UK; to assess potential alternative avenues of medical radioisotope production for the UK market; and to explore ways of mitigating the impact of medical radioisotopes on patient care pathways. The report incorporates details of a visit to the Cyclotron Facilities at Edmonton, Alberta and at TRIUMF, Vancouver BC in Canada by members of the report team.Comment: 121 page

Interim Evaluation of the Direct Actions under the Euratom Research and Training Programme (2014 - 2018)

This report presents an interim evaluation of the direct actions of the Joint Research Centre (JRC) of the European Commission under the Euratom research and training programme (2014 - 2018), conducted halfway through the programme by a panel of high-level independent experts. The panel had extensive knowledge and experience in matters of Euratom research and the wider responsibilities of the European Commission related to nuclear safety and security in a European and an international context. During the reporting period the JRC has shown the ability to lead through coordination, bringing together its own research efforts with those in the Member States. The JRC concentrated its nuclear work in one directorate and more in general the JRC has given successful follow up to recommendations from previous evaluations. The European knowledge manager for nuclear safety and security; the European voice for nuclear; Responsible for the largest single nuclear research effort of the European Atomic Energy Community, the JRC shows its frontline position in this area in all modesty. As the European Commission’s science and knowledge service, the JRC has an excellent position to communicate reliable information on nuclear matters, not only to the nuclear organisations, but also to the other stakeholders, notably the politicians and the public. The positive conclusions and recommendations at the end of this report should help the JRC and the Commission preparing sound proposals for a Council regulation for the Euratom research and training programme 2019 - 2020 and for the next Euratom programme (2021 - 2025).JRC.ADV02-Adviser for Evaluation and Scientific Integrit